Angewandte
Chemie
DOI: 10.1002/anie.201002789
Cryptands
Oxidatively Stable, Aqueous Europium(II) Complexes through Steric
and Electronic Manipulation of Cryptand Coordination Chemistry**
Nipuni-Dhanesha H. Gamage, Yujiang Mei, Joel Garcia, and Matthew J. Allen*
The magnetic and optical properties of the divalent state of
europium make this ion extremely attractive for use in
materials,[1] catalysis,[2] luminescence,[3] magnetic,[4] and diag-
nostic-medical[5] applications. A major hin-
drance to the use of EuII in many of these
applications is the extreme propensity of the
ion to oxidize to EuIII, especially in aqueous
solution. Research efforts aimed at increas-
ing the stability of aqueous EuII have yielded
little success:[6,7] even the most stable aque-
ous EuII complex reported (4,7,13,16,21,24-
hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
europium(II), 1-Eu) is not stable enough in
aqueous solution for practical use.[8,9] Our
research group has generated EuII com-
plexes in aqueous solution, and here we
report the most oxidatively-stable aqueous
EuII complexes known.
cryptand 1 to coordinate EuII over EuIII. To implement these
strategies, we studied cryptands 1–6 (Scheme 1).
Scheme 1. Ligands used to observe trends in oxidative stability of aqueous EuII.
Our strategy for favoring EuII over EuIII
in aqueous solution involves the synthesis
and use of ligands that would preferentially
coordinate to large, soft, electron-rich
metals like EuII. The template for our ligand design was
cryptand 1 because 1-Eu is the most oxidatively-stable,
aqueous EuII complex previously reported.[8] The stability of
1-Eu is partially due to the better size match of the cavity of
cryptand 1 (1.4 ꢀ) to the EuII ion (1.25 ꢀ) relative to the EuIII
ion (1.07 ꢀ).[10] We hypothesized that further oxidative
stabilization could be achieved by modifying the structure
of cryptand 1 using four principles of coordination chemistry
to stabilize electron-rich metals.[6,11] Specifically, our goals
were 1) to increase the steric bulk surrounding cryptand 1 to
minimize interactions between EuII and its environment; 2) to
reduce the Lewis basicity of cryptand 1 to favor the electron-
rich EuII over EuIII; 3) to change the cavity size of the
cryptand to match the size of the EuII ion preferentially; and
4) to modify the hard–soft, acid–base (HSAB) properties of
To increase the steric bulk of 1, methyl groups were added
to the ethylene carbon atoms between the oxygen atoms
resulting in ligand 2. This methyl substitution pattern was
chosen because metal–environment interactions occur
between the unmodified ethylene groups.[8] Furthermore, to
examine the influence of Lewis basicity on oxidative stability,
phenyl rings were introduced to decrease the electron-
donating ability of the adjacent oxygen atoms of ligands 3–5
by a resonance withdrawing effect.[12] The extent of electron
withdrawal was modulated by varying the electron density of
the phenyl ring through the addition of a fluorine atom (4) or
by increasing the number of rings (5). Phenyl-ring-containing
cryptands 3–5 also have an influence on cavity size because
each phenyl ring decreases the cavity size of the cryptand. We
expected the seemingly minor influence of the phenyl rings on
cavity size to have a noticeable effect on the oxidative
stability of EuII because of selectivity studies with Group 2
cations using cryptands 1, 3, and 5.[13] Finally, relatively soft
sulfur-atom donors were introduced in cryptand 6 in place of
oxygen-atom donors to explore the HSAB preferences for the
softer EuII ion relative to the harder EuIII ion.
[*] N.-D. H. Gamage, Dr. Y. Mei, J. Garcia, Prof. M. J. Allen
Department of Chemistry
Wayne State University
5101 Cass Avenue, Detroit, MI 48202 (USA)
Fax: (+1)313-577-8822
E-mail: mallen@chem.wayne.edu
To synthesize the diverse set of cryptands 1–6, a three-step
procedure was devised that involved common intermediates
7, 9, and 11 (Scheme 2).[14] Briefly, the synthesis involved the
conversion of the appropriate ethylenediols or catechols into
the corresponding ditosylates (7, 9, and 11) and subsequent
ring closure with 1,4,10,13-tetraoxa-7,16-diazacyclooctade-
cane, 2,2’-(ethylenedioxy)bis(ethylamine), or 1,4,10,13-tetra-
[**] This research was supported by start-up funds from Wayne State
University and a Pathway to Independence Career Transition Award
(R00EB007129) from the National Institute of Biomedical Imaging
and Bioengineering of the National Institutes of Health.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2010, 49, 8923 –8925
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
8923